ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
November 08, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
Third Quarter 2023 Financial Results -- Record quarterly net revenues of $131.8 million, representing year-over-year growth of 57.3%; net income available to common shareholders of $9.5 million and...
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
October 30, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey,...
ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET
October 25, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financial...
ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares
October 02, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
Cortrophin Gel is the only FDA-approved purified corticotropin (ACTH) indicated for the treatment of appropriate patients with acute gouty arthritis flares New 1-mL size furthers ANI’s commitment to...
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
September 18, 2023 16:05 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey,...
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
September 12, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval...
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
August 28, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for...
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 24, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey,...
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
August 23, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
-- Mr. Leonard is an accomplished leader with 35 years of pharmaceuticals and healthcare experience -- Mr. Leonard has significant expertise in pharmacy benefits management, health insurance, and...
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
August 09, 2023 06:50 ET
|
ANI Pharmaceuticals, Inc.
Second Quarter 2023 Financial Results -- Record quarterly net revenues of $116.5 million, representing year-over-year growth of 57.8%; net income available to common shareholders of $5.8 million and...